Discovery Programs
Sunesis has a number of preclinical programs in oncology, focusing on inhibitors of the cell cycle and molecules that block the growth and survival signals required to sustain tumor biology.
Aurora A
Sunesis has also identified selective inhibitors of Aurora A kinase, and is evaluating these molecules in in vivo settings to select rational indications and combination regimens.
Get general information about clinical studies, and learn about Sunesis investigational drugs currently in clinical trial.
Get information about our developing oncology medicines and find resources to support you in the fight against cancer.
Copyright © Sunesis Pharmaceuticals, Inc. 2007. All Rights Reserved.